ArticleCancers2024

Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell Lymphoma.

Clare M Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.